Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adult Women
11%
Biobank
11%
Biologic Immunomodulators
11%
Biological Agents
66%
Cervical Cancer
11%
Cervical Neoplasia
100%
Cervical Screening
11%
Counseling
11%
Cumulative Exposure
100%
Cyclosporine
11%
Cytopathology
11%
Dutch
11%
High-grade Cervical Intraepithelial Neoplasia
11%
Immunomodulator
100%
Immunomodulatory Drugs (IMiDs)
22%
Immunosuppressive Drugs
22%
Incidence Rate
11%
Inflammatory Bowel Disease
100%
Methotrexate
11%
Multivariate Analysis
11%
Patient Characteristics
11%
Risk Factors
22%
Screening Frequency
11%
Tacrolimus
11%
Thiopurines
11%
Time-dependent Cox Model
11%
Tumor Necrosis Factor-α
11%
Ustekinumab
11%
Vedolizumab
11%
Years of Exposure
11%
INIS
adults
11%
assessments
11%
cancer
11%
comparative evaluations
11%
cyclosporine
11%
detection
11%
diseases
100%
immunosuppressive drugs
22%
inflammation
100%
methotrexate
11%
multivariate analysis
11%
patients
22%
risks
100%
screening
33%
time dependence
11%
tumor necrosis factor
11%
women
100%
Medicine and Dentistry
Cervical Cancer
11%
Cervical Intraepithelial Neoplasia
11%
Cervical Screening
11%
Cohort Analysis
11%
Counseling
11%
Cox Regression Model
11%
Cyclosporine
11%
Cytopathology
11%
Immunomodulating Agent
100%
Immunosuppressive Drug
22%
Inflammatory Bowel Disease
100%
Median Follow Up
11%
Mercaptopurine
11%
Methotrexate
11%
Multivariate Analysis
11%
Neoplasm
100%
Tacrolimus
11%
TNF Inhibitor
11%
Ustekinumab
11%
Vedolizumab
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
11%
Cohort Study
11%
Immunomodulating Agent
100%
Immunosuppressive Agent
22%
Inflammatory Bowel Disease
100%
Mercaptopurine
11%
Methotrexate
11%
Neoplasm
100%
Tacrolimus
11%
Tumor Necrosis Factor Inhibitor
11%
Ustekinumab
11%
Uterine Cervix Cancer
11%
Uterine Cervix Carcinoma in Situ
11%
Vedolizumab
11%